Laurel Wealth Advisors (North Carolina)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-300
Closed -$1K 627
2022
Q2
$1K Hold
300
﹤0.01% 621
2022
Q1
$1K Hold
300
﹤0.01% 657
2021
Q4
$1K Hold
300
﹤0.01% 657
2021
Q3
$2K Hold
300
﹤0.01% 621
2021
Q2
$3K Buy
+300
New +$3K ﹤0.01% 650
2021
Q1
Sell
-861
Closed -$6K 680
2020
Q4
$6K Buy
+861
New +$6K ﹤0.01% 466